menthol; methyl salicylate · Hisamitsu Pharm Co · NDA 022029
Salonpas
Earliest generic entry, as listed · earliest of 2 marketed strengths
3 Jan 2030
Blocked by patent: US 8809615.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8809615 | product | 3 Jan 2030 |
| US 9233184 | product | 1 Aug 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022029 · 001 · RLD | patch, topical | 3%;10% | 3 Jan 2030 |
| 022029 · 002 · RLD | patch, topical | 3%;10% | 3 Jan 2030 |